"10.1371_journal.pone.0063891","plos one","2013-05-20T00:00:00Z","Jochen Seitz; Berrak Kahraman-Lanzerath; Tanja Legenbauer; Lea Sarrar; Stephan Herpertz; Harriet Salbach-Andrae; Kerstin Konrad; Beate Herpertz-Dahlmann","Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University Hospital, Aachen, Germany; Clinic for Child and Adolescent Psychiatry, Westphalia-Lippe Regional Association (LWL)-University Hospital Hamm of the Ruhr-University Bochum, Hamm, Germany; Clinic for Audiology and Phoniatry, Charite University Hospital, Berlin, Germany; Clinic for Psychosomatic Medicine and Psychotherapy, Westphalia-Lippe Regional Association (LWL)-University Hospital, Ruhr-University, Bochum Germany; Clinic for Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, Charite University Hospital, Berlin, Germany","Conceived and designed the experiments: KK BHD. Performed the experiments: BKL TL LS SH HSA. Analyzed the data: JS. Contributed reagents/materials/analysis tools: KK BHD SH HSA. Wrote the paper: JS.","KK has received speaking fees from Lilly, Novartis and Medice. BHD and KK have an investigator-initiated trial (IIT) with Vivor AG on the effects of polyunsaturated fatty acids on brain maturation in children with or without ADHD; BHD is a member of Lilly’s advisory board for atomoxetine. None of the above authors is employed by any commercial company. No commercial company was involved in this study in any way. None of the authors receive financial contributions related to an increased sale of any of their products. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Jochen Seitz","JS",8,TRUE,2,5,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
